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Nuclear magnetic resonance (NMR) spectroscopy was used to determine the secondary structure and the three-dimensional polypeptide backbone 
fold of the human sterol carrier protein 2 (hSCPZ), which is a basic protein with 123 residues believed to participate in the intracellular transport 
of cholesterol and various other lipids. Sequence-specific assignments were obtained for nearly all backbone ‘H and 15N resonances, as well as for 
about two-thirds of the side-chain ‘H resonances, using uniform 15N-labeling of the protein combined with homonuclear two-dimensional ‘H NMR 
and three-~mensional r5N-correlated ‘H NMR. Three a-he&s comprising the polypeptide segments of residues 9-22, 25-30 and 78-84 were 
identifi~ by sequential and rn~i~-range nuclear Overhauser effects (NOE). The analysis of long-range backbone-back~ne NOES showed that 
hSCP2 further contains a five-strands &sheet including the residues 33-41,47-54, 60-62, 71-76 and 10&102, which is a central feature of the 
molecular architecture. The first three strands are arranged in an antiparallel fashion, the polypeptide chain then crosses over this three-stranded 
sheet in a right-handed sense so that the fourth strand is added parallel to the first one. The fifth strand runs antiparallel to the fourth one, so 
that the overall topology is + 1, + 1, -3x, - 1. The three-dimensional rrangement of the @sheet and the first two helices was determined using an 
input of 625 NOE upper distance constraints and 95 scalar coupling constants for a preliminary structure calculation with the distance geometry 
program DIANA. 
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1. INTRODUCTION 
The sterol carrier protein 2 (SCPZ, or ‘non-specific 
lipid transfer protein’, NSLTP) is a small basic lipid 
transfer protein which was originally isolated from rat 
liver but has since been detected in a number of other 
tissues and species (see [1,2] for recent reviews). The 
hypothesis that SCP2 participates in the intracellular 
transport of sterols and lipids is based upon the finding 
that the protein catalyses the in vitro transport through 
membranes of a wide variety of sterols [3] and common 
lipids [4]. Furthermore, it activates the enzymatic con- 
version of 7-dehydro~holesterol to cholesterol [S], the 
acetyl-CoA cholesterol acyltransferase-mediated steri- 
fication of cholesterol [G--8], and catalyzes in vitro the 
introduction of the less polar substrates in bile acid 
biosynthesis to the membrane-bound enzymes 19, lo], 
suggesting that SCP2 plays an important role in steroid 
metabolism. Apart from the liver, the protein is most 
prominently expressed in the adrenals [111, which led to 
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the proposal that SCP2 is likewise required for the intra- 
cellular transfer of cholesterol during pregnenolone syn- 
thesis in this tissue [ll-131. Furthermore, the recent 
identification of an oleic acid-inducible SCP2 homo- 
logue in Cundida tropicalis [14] points to a high degree 
of evolutionary conservation, which is another indica- 
tion that SCP2 might be of key importance for the 
cellular lipid metabolism. 
In contrast to the wide array of implicated functional 
roles for SCP2, very little is known so far about the 
structural basis of these functions. Nucleotide sequenc- 
ing of SCPZencoding cDNAs revealed that rat, mouse 
and human SCP2 are synthesized as 143-amino acid 
precursor proteins (pre-SCP2), with post-translational 
processing to the mature SCP2s comprising 123 amino 
acid residues [15-201. Purified SCP2 does not contain 
any bound lipid [11,21], and no high-affinity binding of 
radio-labeled sterols to SCP2 was observed in vitro [4]. 
It has therefore been proposed that SCP2 does not func- 
tion as a typical lipid carrier protein, but might be 
bound as a connecting tunnel between lipid interphases 
by electrostatic interactions to membrane surfaces, and 
thus facilitates transfer of hydrophobic molecules from 
a donor to an acceptor membrane [4]. Other observa- 
tions by site-directed mutagenesis of SCP2, however, 
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favour the existence of a local lipid-binding site [22] and 
indicate that SCP2 shields the bound lipids from the 
aqueous phase as would be expected for a typical lipid- 
carrier protein [23]. To obtain a more detailed structural 
basis of SCPZmediated lipid transport, we have started 
an NMR structure determination in solution. This 
paper reports sequence-specific resonance assignments 
and a determination of the secondary structure and the 
global polypeptide backbone fold. 
2. MATERIALS AND METHODS 
2.1. Preparation of human SCP2 with natural isotope content and uni- 
form ‘5N-labeling 
A cDNA encoding human pre-SCP2 was isolated from a liver A- 
gtl 1 cDNA library (clone PBS-hSCP2; [22]). This clone was used as 
a template for PCR amplifications using 5’ and 3’ oligonucleotide 
primers that introduce BumHI and EcoRI restriction sites at the 5’ and 
3’ ends of the amplified DNA fragments. The DNA fragments thus 
obtained were digested with BamHI and EcoRI, cloned directionally 
into the corresponding restriction sites of the vector pGEX-2T [24,25], 
and the resulting construct pGEX-2T/hSCP2 was verified by nucleo- 
tide sequencing. E. coli XL-l Blue (Stratagene, La Jolla, USA) trans- 
formed with the vector pGEX-2T/hSCP2 were grown to an OD, of 
~0.8 in a 20 1 bioreactor (MBR - Sulze.r, Wetzikon, Switzerland) and 
expression was induced by the addition of IPTG (Boehringer 
Mannheim, Mannheim, Germany) to a final concentration of 0.1 mM. 
After 5 h of further fermentation, the glutathione S-transferase (GST) 
fusion protein was extracted and purified [24,25], dialysed against 100 
vol. of phosphate-buffered saline, cleaved by incubation for 2 h at 
37°C with 1:20 (w/w) thrombin (Sigma, St. Louis, USA), and GST was 
then removed by affinity chromatography over glutathione sepharose 
4B (Pharmacia, Uppsala, Sweden). The flow-through was dialysed 
against 100 vol. of 50 mM NaCl, 50 mM Tris-HCl, pH 8.6, and the 
hSCP2 was further purified to homogeneity via passage over DEAE- 
Sephadex equilibrated with the same buffer. Protein concentrations 
were determined using the Bradford assay [26], and sterol carrier and 
lipid transfer assays of purified recombinant hSCP2 performed as 
described in [22]. Protein sequencing of the N-terminal 20 residues 
showed that the recombinant hSCP2 contained an extra N-terminal 
Gly-Ser dipeptide due to the introduction of the BarnHI-linker se- 
quence. 
To prepare uniformly “N-labeled hSCP2,200 ml of an overnight 
culture of XL-l Blue/pGEX-ZT/hSCPZ grown in doubly-concentrated 
yeast ryptone medium were used to inoculate 8 1 of a minimal medium 
consisting of M9 medium supplemented with 60 ml of 20% glucose, 
0.5 ml of 2% thiamine, 5 ml of 10 mg/ml of ampicillin, and 1 g of 
(NH&SO4 per litre. After growing the bacteria at 37°C on a rotary 
shaker at 250 rpm to an ODm of 0.6, the culture was collected by 
centrifugation at 3,000 x g for 15 min and resuspended at an OD, 
of 1 .O in the above minimal medium containing 1 g/l of (‘5NH&S0, 
and 0.2 mM IPTG. After incubation at 37°C on a rotary shaker at 
250 rpm for 8 h, the bacteria were collected by centrifugation at 
3,000 x g for 15 min and the “N-labeled hSCP2 was isolated and 
purified as described above. 
For the NMR experiments, 0.3 mM solutions of hSCP2 in 15 mM 
KH,P0,/5 mM dithiothreitol (DTT) at pH = 6.0 were concentrated 
to about 1.5 mM by ultrafiltration in a Centricon 3 microconcentrator 
(Amicon, USA) at 22°C. 30 ~1 of DzO were added to 400 ~1 of the 
concentrated solution, and the sample was kept in a 5 mm NMR tube 
under argon. NMR spectra were recorded at pH = 6.0. Between NMR 
measurements he samples were stored at 4°C. 
2.2. NMR specrroscopy 
All NMR spectra were recorded on an Bruker AMX 600 spectrome- 
ter and quadrature detection in the indirectly detected imensions was 
obtained using the States-TPPI method [271. For the data processing 
we used the program PROSA [28]. The ‘H chemical shifts at 36°C are 
relative to the water resonance at 4.65 ppm from [2,2,3,3-D,]-trime- 
thylsilyl-propionate (TSP). Two-dimensional (2D) [‘H,‘H]-NOESY 
spectra with 100 ms mixing time [29] were recorded at 36°C in H,O 
and D,O as data matrices with 256 (t,) * 512 (tJ complex points 
01, = 29.2 ms, tz,,,, = 65.5 ms) in approximately 24 h. A clean- 
TOCSY spectrum [30] in H,O with a mixing time of 50 ms was 
recorded with the same data size and measurement time. The intensity 
of the H,O signal was suppressed by irradiation during the relaxation 
delay and further reduced with the convolution method of Marion et 
al. [31]. The data sets were multiplied in both dimensions with phase- 
shifted sine-bell functions [32] and the baseline was corrected as de- 
scribed by Giintert and Wiithrich [33]. The digital resolution after 
zero-filling was 15 Hz along w, and 7.6 Hz along at. 
2D and three-dimensional (3D) heteronuclear NMR experiments 
were performed at 36, 28 and 22°C. The intensity of the H,O signal 
was reduced using spin-lock purge pulses [34], and a WALTZ-16 
scheme [35] was applied to decouple 15N during the acquisition. (i) At 
36”C, a 2D [“N,‘H]-HSQC experiment [36] was recorded with 186 (t,) 
* 1024 (t2) complex points (t,, = 100 ms, rzmax = 131 ms) and a 
measurement time of about 24 h. A 3D “N-resolved [‘H,‘H]-TOCSY 
experiment [37,38] using a mixing time of 50 ms, a 3D ‘5N-resolved 
[‘H,‘H]-NOESY experiment [37-391 using a mixing time of 100 ms, 
and a 3D cr-HNNHB experiment [40,41] were recorded with 32 (t,) 
* 212 (Q * 512 (t3) complex points (t,,,_ = 17.3 ms, t2_ = 28.0 ms, 
t 3mnr = 65.5 ms) in about 3 days each. Prior to Fourier transformation 
the water signal was further reduced by convolution [31], the number 
of complex points in t, was increased to 48 by linear prediction [42], 
the data sets were multiplied in all dimensions with phase-shifted 
sine-bell functions [32] and baseline corrected [33]. The digital resolu- 
tion after zero-filling was 3.6 Hz along w, and 1.9 Hz along w2 for the 
2D spectrum, and 14.8 Hz, 28.9 Hz, and 7.6 Hz along w,, w2 and ol, 
respectively, for the 3D spectra. A 2D ‘5N(w,,w&double-half filter 
[‘H,‘H]-NOESY spectrum [43] using a mixing time of 100 ms with 256 
(t,) * 512 (&) complex points (t,,, = 33.3 ms, t,,, = 65.5 ms) was 
recorded in about 2 days and processed as described above for the 
[‘H,‘H]-NOESY. (ii) At 28’C, 2D [“N,‘H]-HSQC, 3D “N-resolved 
[‘H,‘H]-TOCSY and “N-resolved [‘H,‘H]-NOESY spectra were re- 
corded with similar parameters as in (i). (iii) At 22”C, a 2D [15N,‘H]- 
HSQC, a 2D ‘H-TOCSY- relayed [“N,‘H]-COSY, and a 2D ‘H- 
NOESY-relayed [“N,‘H]-COSY experiment with a mixing time of 100 
ms were recorded with 112 (tJ * 512 (13 complex points (flmar =60.5 
ms, t2_ = 131 ms) and processed as described for the 2D [“N,‘H]- 
HSQC experiment at 36°C. The water chemical shift references used 
were 4.72 ppm at 28”C, and 4.80 ppm at 22°C. 
The vicinal scalar coupling constants ‘JNH, were extracted by in- 
verse Fourier transformation of in-phase multiplets from the 2D 
[‘5N,‘H]-HSQC spectra at 36°C and 28’C [44]. 
Slowly exchanging amide protons were identified at 22°C in 2D 
[‘5N,1H]-HSQC experiments of the “N-labeled protein dissolved in 
D,O. The sample was prepared at 4°C over a time period of 5 h, which 
included dialysis against D,O and concentration over a Centricon 3 
microconcentrator. A series of 2D [‘5N,‘H]-COSY experiments was 
acquired, i.e., three groups of 4 spectra with recording times of 15, 30 
and 60 min per spectrum, respectively, and 12 spectra with recording 
times of 4 h each. Data matrices of 96 (t,) * 1024 (tJ complex points 
(2 ,msl = 52 ms, lZmax = 65.5 ms) were recorded and processed as de- 
scribed for the other 15N-correlated 2D spectra. The cross peak vol- 
umes were integrated using the program EASY [45], and the exchange 
rates were obtained from a least-squares fit of a single exponential 
function to the experimental data. 
To collect the input for the preliminary structure calculations, the 
3D ‘5N-resolved [‘H,‘H]-NOESY spectra were integrated with the 
home-written program PEAKINT (N. Schtifer, C. Bartels and K. 
Wiithrich, unpublished), and NOES with the aromatic spin systems 
were integrated in the 2D ‘H-NOESY spectra with the program EASY 
[45]. The 3D and 2D cross peak volumes were converted to upper 
distance limits with the program CALIBA [46]. Dihedral angle con- 
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Fig. 1. Amino acid sequence of hSCP2, sequential and medium-range NOE connectivities, identification of slowly exchanging amide protons, and 
‘JM, coupling constants. The lower case letters identify an N-terminal dipeptide segment that originates from the overexpression system. Boxes 
above the sequence represent amide protons with exchange rate constants < 7. lo-’ min- ’ in D,O solution at pD = 6.0 and 22°C. Below the sequence 
the NOE connectivities are indicated where the thickness of the bars for the sequential connectivities represents the NOE intensities. The magnitude 
of the vicinal scalar coupling constants ‘J,yH, is represented by a black bar below the NOE connectivities, which covers the range from 10 f 1 Hz 
(Thr74) to 3 f 1 Hz (Asp’O). The sequence locations of the secondary structure elements identified from the data in this figure and the structure 
calculations with the program DIANA are indicated at the bottom. 
straints based on local NOE distance constraints and on the scalar 
coupling constants ‘JNHrr were generated with the program HABAS 
[47]. Structure calculations were done using the program DIANA 
[46,48] with four REDAC cycles, where the maximal target function 
value per residue for locally acceptable segments was set to C”’ = 
0.6 A2, Co’ = 0.4 A’, Co’ = 0.4 A’ and C4) = 0.3 A’, respectively [49]. 
3. RESULTS 
Fig. 1 shows the 125-residue hSCP2 polypeptide ob- 
tained from the overexpression system used, where the 
first two residues are not part of natural hSCP2. For a 
general characterization, the thermal denaturation was 
monitored by Circular Dichroism (CD) at 222 nm, 
which yielded a melting point of about 70°C at 
pH = 6.0, whereby the unfolding was irreversible. The 
maximal solubility of hSCP2 in H,O at pH = 6.0 con- 
taining 15 mM phosphate buffer was found to be ap- 
proximately 1.5 mM at 22°C. Due to the single Cys” 
(Fig. l), hSCP2 is prone to oxidative dimerization at 
higher concentrations, and therefore all measurements 
were performed in the presence of 5 mM DTT under 
20 
Volume 335, number I FEBS LETTERS November 1993 
104 
q ?N> 
(PPm) 
117 
130 
9 
* 
,42 *St) 
IO6 
,X5 
h - 
97 
r-45 
*X6 
-44 
1X 
. . 103 
60 
12.5 12.0 
. 
‘ii9 
51 
m2C1HN) (ppm
Fig. 2. Contour plot of a 2D [‘SN,‘H]-HSQC spectrum of hSCP2 uniformly labeled with “N, (‘H frequency = 600 MHz, protein concentration = 1.3 
mM in 90% H,O/lO% D,O with 15 mM KH,P04/5 mM DTT, pH = 6.0, T = 36°C). The cross peaks are marked with the amino acid residue 
numbers. 
Argon. A 2D [lSN,‘H]-HSQC spectrum recorded at 
36°C (Fig. 2) shows good chemical shift dispersion in 
both dimensions, but the signals of some residues are 
very weak, which is probably due to confo~ational 
exchange processes on a millisecond time scale. We sub- 
sequently recorded NMR spectra at multiple tempera- 
tures in order to obtain complementary information for 
those residues that are affected by these presumed ex- 
change processes. 
3.1. Sequence-specijic resonance assignments 
The 2D [“N,‘H]-HSQC spectrum of Fig. 2 was the 
starting point for obtaining sequence-specific ‘H reso- 
nance assignments of hSCP2. Using the program 
XEASY (C. Bartels, T.H. Xia, M. Billeter, P. Giintert 
and K. W~th~ch, to be published), the “N and ‘H 
chemical shifts obtained from Fig. 2 were taken to de- 
fine the corresponding positions along w*(‘~N) and 
W&H) in a 3D “N-resolved [‘H,‘H]-TOCSY experi- 
ment [37,38]. Comparison with the 3D ct-HNNHB 
spectrum [40,41] enabled the unambiguous identifica- 
tion of the /?-proton resonances of 49 out of the 105 
non-prolyl and non-glycyl spin systems. For 21 addi- 
tional spin systems one of the two &resonances could 
be assigned. 9 out of the 10 alanines could be identified 
and were used together with the 15 glycines as starting 
points for the sequential resonance assignment. Using 
the peak positions of the 3D ‘5N-resolved [‘H,‘H]- 
TOCSY and the 3D ct-HNNHB spectrum, the intrare- 
sidual NOE connectivities in a 3D “N-resolved [‘H,‘H]- 
NOESY experiment [37-391 were distinguish~ from 
the sequential &,.,, dNN and dpH NOE connectivities 
[SO,Sl]. As an illustration, Fig. 3 shows the data used 
for the assignments from residues 13-22 as a composite 
plot of strips taken from the 3D “N-resolved [‘H,‘H]- 
NOESY spectrum recorded at 36°C. The same proce- 
dure was repeated at 28°C and some NOE connectivi- 
ties identified only at this temperature are also included 
in Fig. 1. The chemical shift at 28°C and 36°C were 
found to be nearly identical. 
Overall, sequence-specific polypeptide backbone as- 
signments were obtained for the 109 residues 2--42,44 
62, 64-88, 92-104, 106111 and 119-123; at least one 
sequential connectivity was found for all pairs of as- 
signed neighbouring residues (Fig. 1). For 69 residues 
the complete ‘H spin systems could be assigned, and for 
an additional 38 residues it was possible to identify the 
p-proton resonances in addition to the backbone reso- 
nances. The resulting ‘H and the “N chemical shifts will 
be presented elsewhere. 
3.2. Assignment of the aromatic spin systems 
The aromatic spin systems were assigned using the 
standard strategy for unlabeled proteins [51]. For the 
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Fig. 3. Composite plot of &H&T&H) strips taken from the 3D “N-resolved (‘H,‘H]-NOESY spectrum of hSCP2 at 36”C, which shows the 
sequential connectivities in the a-helicai polypeptide segment from Fhe13 to C1uz2 (protein concentration 1.3 mM, solvent 90% H+I3/10% D,O with 
15 mM K&PO4 and 5 mM D’IX, pH = 6.0, mixing time = 100 ms, ‘H frequency 600 MHz). The individual strips with a width of 0.1 ppm along 
w, were taken from ~,(‘H~~(‘H) pIanes at different w,(“N) chemical shifts and centred about the amide proton chemical shift of the residue 
~nd~~t~ at the top. The strips are ordered according to the amino acid sequence. Squares and circles identify the diagonal peaks of the amide 
protons, and the sequentiaf dMX, dwv and $v connectivities, respectively (see atso Fig. I). 
unique spin system of Trp”‘, the &- and #-proton reso- 
nances were identified in the 3D “N-resolved spectra, 
and the other ring protons were assigned in a 2D ‘H- 
NOESY spectrum recorded in D,O and a “N~~,,#~~- 
double-half-filtered [lH,lH]-NOESY spectrum recorded 
in I&Q. The eight Fhe rings exhibit sufficiently large 
chemical shift dispersion so that NOE ~o~ne~~ties of 
the S-protons with the a- an&or ~“protons could thus 
t>e ~ambi~ousiy identified, and the resonances of the 
E- and c-ring protons were subsequently identi~~d by 
combined use of 2D NOESY and 2D TOCSY spectra. 
In addition, for seven of the eight phenylalanines, NOES 
from the S-protons to the backbone amide protons were 
observed in 3D “N-resolved [‘H,‘H]-NOES-Y spectra. 
3.3. ~~~~~~~ i~~~~~~e of hSCP2 
A large number of medium-rage and long-range 
NOES could be identified in the 30 “N-resolved 
22 
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[‘H,‘H]-NOESY spectra recorded at 28°C and 36°C. 
The sequential and medium-range connectivities to- 
gether with the ‘JNHa coupling constants and the identi- 
fication of slowly exchanging amide protons (Fig. 1) 
resulted in the determination of three helices and five 
b-strands. Four criteria were used to support the pres- 
ence of the helices: (i) 3JNHa coupling constants c 6.0 Hz 
[52]; (ii) strong sequential dN,,, connectivities [50]; (iii) a 
significant number of daNci,i + 3j connectivities character- 
istic of os-helices [53]; (iv) slow amide proton exchange 
rates for most residues in the helical polypeptide seg- 
ments [51]. The helices A, B and C were thus found in 
the polypeptide segments 9-22, 25-30 and 78-84 (Figs. 
1 and 4A). Due to the long preparation time of about 
5 h for the D20 sample, only an incomplete set of slowly 
exchanging amide protons was registered. 
The identification of the B-strands and their relative 
orientation in the B-sheet was based upon: (i) 3JNH, 
coupling constants > 8.0 Hz [52]; (ii) strong sequential 
daN connectivities [50]; (iii) a significant number of inter- 
strand da,,, and dNN connectivities defining the topology 
of the p-sheet [51]; (iv) alternating slow and fast amide 
Fig. 4. (A) Secondary structure elements and topology of the /?-sheet of hSCP2 identified on the basis of sequential and medium-range NOES (see 
also Fig. 1) and long-range backbone-backbone interstrand NOES in the &sheet. The start and the end of the secondary structure elements, as 
well as the N- and the C-terminus of the polypeptide chain are marked with their sequence locations. The dashed line connecting residues 62 and 
7 1 indicates that the polypeptide chain crosses below the plane defmed by the/&sheet. (B) The five-stranded&sheet ofhSCP2 in the same orientation 
as in (A). Thin lines identify assigned interstrand NOES and slowly exchanging amide protons are marked with boxes (see also Fig. 1). 
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proton exchange rates in the peripheral strands of the 
B-sheet, and continuous stretches of residues with 
slowly exchanging amide protons in the central strands 
[51]. Using the criteria (i) and (ii) we identified five 
P-strands with residues 3341,47-54,60-62, 71-76 and 
10&102. The amide proton exchange data (Fig. 1) sug- 
gested that strands 3 and 5 are peripheral, whereas con- 
tinuous stretches of slowly exchanging amide protons 
supported that strands 1,2 and 4 are in non-peripheral 
locations. 28 interstrand backbone-backbone NOE 
~onnectivities revealed the presence of a mixed, five- 
stranded p-sheet. The first three strands comprising res- 
idues 33-41,47-54 and 60-62, are arranged in an anti- 
parallel fashion, the polypeptide chain then crosses over 
this three-stranded sheet in a right-handed sense so that 
the fourth strand with residues 71-76 is added parallel 
to the first one, The fifth strand comprising residues 
100-102 runs antiparallel to the fourth one, so that the 
overall topology [54] is +l, +l, -3x, -1 (Fig. 4). 
3.4. Calculation of the three-dimensional polypeptide 
fold 
For a preliminary calculation of the complete three- 
dimensional structure of hSCP2 we used an input of 625 
NOE upper distance constraints (235 intraresidual, 123 
sequential, 87 medium-range and long-range back- 
bone-backbone, and 180 interresidual constraints with 
side chain protons) derived from the homonuclear 2D 
‘H-NOESY spectra and the 3D “N-resolved [‘H,‘H]- 
NOESY spectra recorded at 28°C and 36°C. In addi- 
tion, the input contained 95 vicinal ‘JNN, scalar cou- 
pling constants. Thus, although no amino acid side 
chain conformations are discussed in this paper, the 
calculation of the backbone fold was based on assign- 
ments of numerous medium-range and long-range NOE 
distance constraints that also include side chain hydro- 
gen atoms. The following local average pairwise RMSD 
values relative to the mean structures were obtained for 
the residues forming the secondary structure elements: 
0.88 A for helix A (residues 9-22), 0.69 A for helix B 
(25-30) 1.24 A for helix C (78-84) and 1.28 A for the 
p-sheet (33.-41,47-54, 60-62,71-76, lOO-102) showing 
that all regular secondary structure elements that have 
been identified are locally well defined. Fig. 5 shows a 
superposition of the backbone heavy atoms of helices 
A and B and the p-sheet of the 20 DIANA conformers 
with the lowest target function value. The average 
pairwise root mean squared deviation (RMSD) after 
superposition of the backbone atoms N, C” and C’ rel- 
ative to their mean structure was calculated to be 2.0 A 
for this substructure of hSCP2 comprising the residues 
9-22, 25-30, 35-40, 47-54, 71-76 and lOO--102. The 
relative orientation of the helices A and B and the p- 
sheet is quite well defined, but the orientation of helix 
C relative to the remainder of the molecule is not yet 
well defined. Fig. 5B shows a ribbon drawing of the 
residues 8-76 and 99-103 of the DIANA conformer of 
(a) 
(b) 
Fig. 5. ark-Dimensions a~angement of the B-sheet and the hehces 
A and B as obtained from DIANA structure calculations. (A) Stereo 
view of the polypeptide backbone heavy atom representation of the 
20 DIANA conformers of hSCP2 with the lowest target function 
values, which were superimposed for minimal RMSD of the backbone 
atoms N, Ca and C’ of the residues in the helices A and B and the 
p-sheet. (B) Ribbon drawing generated with the program 
MOLSCRIPT [56] of residues 8-76 and 99-103 of the DIANA con- 
former of hSCP2 with the lowest target function value, comprising all 
regular secondary structure elements except helix C. The helices and 
b-strands are labeled as in Fig. 1. 
hSCP2 with the lowest target function, which includes 
all regular secondary structure elements except for helix 
C. 
4. DISCUSSION 
A preliminary evaluation of previously reported ef- 
fects of site-directed mutagenesis on SCP2 activity [22] 
in the light of the presently described regulary second- 
ary structure and the three-dimensional polypeptide 
backbone fold of hSCP2 leads to the following intrigu- 
ing observations. (i) Whereas N-terminal deletion of 7 
amino acid residues had only a relatively small effect, 
deletion of 12 residues, which directly affects the helix 
A from residues 9 to 22, resulted in almost complete loss 
of activity. In a different experiment, disruption of the 
amphipathicity of helix A resulted in complete loss of 
activity [22], providing additional indication that this 
helix represents an essential structural element for the 
lipid transport activity of SCP2. However, whether 
helix A participates in the formation of a hydrophobic 
lipid binding site or is involved in stabilizing the overall 
fold of the protein cannot presently be answered. We 
hope that ongoing studies of the interaction of SCP2 
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with different transport substrates will answer this ques- 
tion (ii) The region from Met”’ to the C-terminus was 
shown to be of minor importance for the lipid transport 
activity, as C-terminal deletion of 18 residues resulted 
in high residual activity, whereas deletion of 5 addi- 
tional residues to Lyr?” resulted in almost complete 
inactivation [22]. Therefore, it was concluded from the 
functional evidence that residues between positions 100 
and IO4 are essential for SCP2 activity. lnterestin~y, we 
now find that residues 100 to 102 form the small /I- 
strand V (Fig. 4), which participates in the formation of 
the central p-sheet. (iii) Substitution of Asn’04, which is 
located in close vicinity of the B-strand V, with different 
amino acids also has profound effects on SCP2 activity. 
Taken together, these findings indicate that residues 
within or close to the core part of the protein with the 
helices A, B and C and the &strands I to V appear to 
be sufficient for the lipid transport activity of SCP2. 
The NMR determination of the regular secondary 
structure elements and the preliminary structure calcu- 
lations revealed a distinctive c+3 tertiary fold (Fig. 5B) 
for hSCP2. No near-identity can be found with any of 
the protein folding types that have recently been sur- 
veyed by Thornton’s group [55f. Furthermore, a se- 
quence homology search using the SWISS-PROT data 
bank did not yield any sequence with a homology larger 
than 30% identity, with the sole exception of PXP18, 
which is a yeast homologue of hSCP2. It therefore 
seems quite likely that elucidation of the mechanisms by 
which hSCP2 mediates lipid transfer might lead to the 
discovery of a novel mechanism of protein-mediated 
sterol and lipid transfer. 
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